# eHealth, Inc.: overview EHTH · Nasdaq · CIK 1333493 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ehth.md) · [Financials](/companies/ehth/financials.md) · [Filings](/companies/ehth/filings.md) · [Insiders](/companies/ehth/insiders.md) Latest reported revenue: [$33.6m](/filings/0001333493-26-000036.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001333493-26-000036). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [58.4](/filings/0001333493-25-000111.md) | [315 d](/filings/0001333493-26-000010.md) | [113](/filings/0001333493-26-000027.md) | [60.8](/filings/0001333493-26-000036.md) | [53.9](/filings/0001333493-25-000111.md) | [326 d](/filings/0001333493-26-000010.md) | [88.0](/filings/0001333493-26-000027.md) | [33.6](/filings/0001333493-26-000036.md) | | Gross margin | % | [(6.5%)](/filings/0001333493-25-000111.md) | [52.0% d](/filings/0001333493-26-000010.md) | [36.9%](/filings/0001333493-26-000027.md) | [31.1%](/filings/0001333493-26-000036.md) | [(0.3%)](/filings/0001333493-25-000111.md) | [55.3% d](/filings/0001333493-26-000010.md) | [41.7%](/filings/0001333493-26-000027.md) | [15.3%](/filings/0001333493-26-000036.md) | | Operating margin | % | [(74.0%)](/filings/0001333493-25-000111.md) | [35.7% d](/filings/0001333493-26-000010.md) | [4.2%](/filings/0001333493-26-000027.md) | [(37.9%)](/filings/0001333493-26-000036.md) | [(77.1%)](/filings/0001333493-25-000111.md) | [38.7% d](/filings/0001333493-26-000010.md) | [(3.3%)](/filings/0001333493-26-000027.md) | [(81.8%)](/filings/0001333493-26-000036.md) | | Net margin | % | [(72.7%)](/filings/0001333493-25-000111.md) | [30.9% d](/filings/0001333493-26-000010.md) | [1.7%](/filings/0001333493-26-000036.md) | [(28.6%)](/filings/0001333493-26-000036.md) | [(58.8%)](/filings/0001333493-25-000111.md) | [26.7% d](/filings/0001333493-26-000010.md) | [(5.4%)](/filings/0001333493-26-000036.md) | [(70.3%)](/filings/0001333493-26-000036.md) | | Diluted EPS | $ per share | [(1.83)](/filings/0001333493-25-000111.md) | not reported | [(0.33)](/filings/0001333493-26-000027.md) | [(0.98)](/filings/0001333493-26-000036.md) | [(1.46)](/filings/0001333493-25-000111.md) | not reported | [(0.58)](/filings/0001333493-26-000027.md) | [(1.18)](/filings/0001333493-26-000036.md) | | Free cash flow | $m | [(30.3) d](/filings/0001333493-25-000111.md) | [(28.3) d](/filings/0001333493-26-000010.md) | [76.8](/filings/0001333493-26-000027.md) | [(42.8) d](/filings/0001333493-26-000036.md) | [(25.5) d](/filings/0001333493-25-000111.md) | [(36.1) d](/filings/0001333493-26-000010.md) | [35.6](/filings/0001333493-26-000027.md) | [(5.4) d](/filings/0001333493-26-000036.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [538](/filings/0001333493-24-000032.md) | [405](/filings/0001333493-24-000032.md) | [453](/filings/0001333493-25-000027.md) | [532](/filings/0001333493-26-000010.md) | [554](/filings/0001333493-26-000010.md) | | Gross margin | % | not reported | not reported | [35.2%](/filings/0001333493-25-000027.md) | [39.2%](/filings/0001333493-26-000010.md) | [43.5%](/filings/0001333493-26-000010.md) | | Operating margin | % | [(23.3%)](/filings/0001333493-24-000032.md) | [(25.3%)](/filings/0001333493-24-000032.md) | [(6.4%)](/filings/0001333493-25-000027.md) | [4.4%](/filings/0001333493-26-000010.md) | [12.0%](/filings/0001333493-26-000010.md) | | Net margin | % | [(19.4%)](/filings/0001333493-24-000032.md) | [(21.9%)](/filings/0001333493-24-000032.md) | [(6.2%)](/filings/0001333493-25-000027.md) | [1.9%](/filings/0001333493-26-000010.md) | [7.2%](/filings/0001333493-26-000010.md) | | Diluted EPS | $ per share | [(4.59)](/filings/0001333493-24-000032.md) | [(4.36)](/filings/0001333493-24-000032.md) | [(2.37)](/filings/0001333493-25-000027.md) | [(1.19)](/filings/0001333493-26-000010.md) | [(0.34)](/filings/0001333493-26-000010.md) | | Free cash flow | $m | [(166)](/filings/0001333493-24-000032.md) | [(27.1)](/filings/0001333493-24-000032.md) | [(8.8)](/filings/0001333493-25-000027.md) | [(20.5)](/filings/0001333493-26-000010.md) | [(27.6)](/filings/0001333493-26-000010.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Gross profit: us-gaap:GrossProfit. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ehth/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $3.4m | 2,288,414 | | Added +573,302 | | [Nantahala Capital Management, LLC](/funds/1472322.md) | 2026-06-30 | $2.6m | 1,761,441 | | Unchanged | | [Nantahala Capital Management, LLC](/funds/1472322.md) | 2026-06-30 | $2.6m | 1,761,441 | | Unchanged | | [Palo Alto Investors LP](/funds/1306923.md) | 2026-06-30 | $2.2m | 1,482,797 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.0m | 1,342,468 | | Reduced −1,349,319 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.8m | 1,180,462 | | Reduced −25,965 | | [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $846.7k | 568,229 | | Added +98,678 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $821.7k | 551,494 | | Reduced −276,706 | | [Assenagon Asset Management S.A.](/funds/1546007.md) | 2026-06-30 | $704.1k | 472,569 | | Added +210,716 | | [Assenagon Asset Management S.A.](/funds/1546007.md) | 2026-06-30 | $704.1k | 472,569 | | Added +210,716 | ## Recent filings [All 1,409 filings](/companies/ehth/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-16 | 20:10 ET | [8-K](/filings/0001333493-26-000040.md) | 3.01 Delisting notice | 0001333493-26-000040 | | 2026-08-05 | 20:23 ET | [10-Q](/filings/0001333493-26-000036.md) | Quarterly report, period 2026-06-30 | 0001333493-26-000036 | | 2026-08-04 | 20:21 ET | [8-K](/filings/0001333493-26-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-26-000033 | | 2026-06-25 | 20:14 ET | [8-K](/filings/0001333493-26-000029.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001333493-26-000029 | | 2026-05-07 | 21:45 ET | [10-Q](/filings/0001333493-26-000027.md) | Quarterly report, period 2026-03-31 | 0001333493-26-000027 | | 2026-05-06 | 20:18 ET | [8-K](/filings/0001333493-26-000025.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001333493-26-000025 | | 2026-04-28 | 20:16 ET | [DEF 14A](/filings/0001333493-26-000020.md) | Proxy statement, period 2026-06-18 | 0001333493-26-000020 | | 2026-03-31 | 20:37 ET | [8-K](/filings/0001333493-26-000014.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001333493-26-000014 | | 2026-02-26 | 21:14 ET | [10-K](/filings/0001333493-26-000010.md) | Annual report, period 2025-12-31 | 0001333493-26-000010 | | 2026-02-25 | 21:21 ET | [8-K](/filings/0001333493-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001333493-26-000007 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001333493-26-000010.md), filed Feb 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b1e80949-45e3-495a-a559-96df7cc5154b) ## About the filer - CIK: 1333493 - Tickers: EHTH - Exchange: Nasdaq - SIC code: 6411 Insurance Agents, Brokers & Service - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.